Brain stimulation shows promise as treatment for cannabis use disorder in people with schizophrenia

Repetitive transcranial magnetic stimulation (rTMS) was associated with a reduction in self-reported cannabis use by up to 60 per cent among people with schizophrenia who have cannabis use disorder (CUD), according to a CAMH-led study just published in the journal NPJ Schizophrenia. The double-blind study is Read more > Read more >

Genetically determined levels of inflammation linked to neuropsychiatric illness

A potential link between inflammation and the structure of specific regions of the brain has been identified by researchers at the University of Birmingham. The study, published today (30 March 2022) in JAMA Psychiatry, may be particularly relevant for neurodevelopmental psychiatric disorders including autism spectrum and schizophrenia. Read more > Read more >